What the PCOS-PMOS Rebrand Tells Us About the State of Women’s Health Research
The announcement in May of 2026 that polycystic ovarian syndrome (PCOS) will be renamed polyendocrine metabolic ovarian syndrome (PMOS) was a genuine milestone. After 14 years of global collaboration, 22,000 survey responses and workshops spanning every inhabited continent, researchers and patients



